Parexel principles for artificial intelligence (AI)
Parexel is committed to the development of innovative, high-value, high-quality use cases for AI. We believe AI provides tools to help manage the increasing complexity of clinical development, including opportunities to expedite development timelines for products to reach patients quicker.
Here we outline our six principles for how Parexel conceives, develops, deploys, and monitors AI applications intended for use in clinical development and throughout our business.
Related Insights
CTB Blog
Modernizing data operations to enable today's Phase 1 trials
Jul 1, 2026
Article
Human-in-the loop AI: a proven approach to streamlining PV case processing and review
Oct 7, 2024
Blog
Regulatory acceptability of AI: Current perspectives
Mar 7, 2024
Blog
Using ethical AI to streamline HEOR
Jan 26, 2024
Video
Insights with Goldman Sachs Part 5: Pioneering new approaches, technologies, and AI to drive innovation
Jan 26, 2024
Blog
Regulatory submissions as a source of insight: How AI can amplify the value of our work
Jul 15, 2026
CTB Blog
Modeling & simulation and artificial intelligence for early drug development
Jul 14, 2026
Blog
Human-centered AI - A dual-layer model for clinical research excellence
Jul 1, 2026
Blog
The connected submission - How AI, automation, and intelligence are changing the regulatory ecosystem
Jul 1, 2026
Whitepaper
AI-powered pharmacovigilance: From reactive reporting to predictive risk
Mar 24, 2025
Podcast
Enabling Successful Sites: Episode 4, Part Two: Leveraging AI to improve patient recruitment and retention
Jan 6, 2025
Whitepaper
Harnessing the Benefits of Externally Controlled Clinical Trials (ECTs) to Accelerate Development of Better Medicines
Nov 25, 2024
Related Insights
CTB Blog
Modernizing data operations to enable today's Phase 1 trials
Jul 1, 2026
Article
Human-in-the loop AI: a proven approach to streamlining PV case processing and review
Oct 7, 2024
Blog
Regulatory acceptability of AI: Current perspectives
Mar 7, 2024
Blog
Using ethical AI to streamline HEOR
Jan 26, 2024
Video
Insights with Goldman Sachs Part 5: Pioneering new approaches, technologies, and AI to drive innovation
Jan 26, 2024
Blog
Regulatory submissions as a source of insight: How AI can amplify the value of our work
Jul 15, 2026
CTB Blog
Modeling & simulation and artificial intelligence for early drug development
Jul 14, 2026
Blog
Human-centered AI - A dual-layer model for clinical research excellence
Jul 1, 2026
Blog
The connected submission - How AI, automation, and intelligence are changing the regulatory ecosystem
Jul 1, 2026
Whitepaper
AI-powered pharmacovigilance: From reactive reporting to predictive risk
Mar 24, 2025
Podcast
Enabling Successful Sites: Episode 4, Part Two: Leveraging AI to improve patient recruitment and retention
Jan 6, 2025
Whitepaper
Harnessing the Benefits of Externally Controlled Clinical Trials (ECTs) to Accelerate Development of Better Medicines
Nov 25, 2024